RADIANT-2 MULTIFACTORIAL ANALYSIS-REFINING USE OF EVEROLIMUS IN NEUROENDOCRINE TUMORS
In patients with advanced neuroendocrine tumors that originate outside the pancreas, a new set of prognostic factors can help identify whic...
Wednesday, January 25, 2012
Comment